Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
Bioorg Med Chem Lett. 2017 May 1;27(9):2069-2073. doi: 10.1016/j.bmcl.2016.10.085. Epub 2016 Oct 31.
Bioorg Med Chem Lett. 2017.
PMID: 28284804
Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus.
Xu J, Lin S, Myers RW, Trujillo ME, Pachanski MJ, Malkani S, Chen HS, Chen Z, Campbell B, Eiermann GJ, Elowe N, Farrer BT, Feng W, Fu Q, Kats-Kagan R, Kavana M, McMasters DR, Mitra K, Tong X, Xu L, Zhang F, Zhang R, Addona GH, Berger JP, Zhang B, Parmee ER.
Xu J, et al. Among authors: kats kagan r.
Bioorg Med Chem Lett. 2017 May 1;27(9):2063-2068. doi: 10.1016/j.bmcl.2016.10.088. Epub 2016 Oct 31.
Bioorg Med Chem Lett. 2017.
PMID: 28284809
Item in Clipboard
The discovery of a novel route to highly substituted α-tropolones enables expedient entry to the core of the gukulenins.
Kats-Kagan R, Herzon SB.
Kats-Kagan R, et al.
Org Lett. 2015 Apr 17;17(8):2030-3. doi: 10.1021/acs.orglett.5b00841. Epub 2015 Apr 3.
Org Lett. 2015.
PMID: 25839211
Item in Clipboard
Cite
Cite